RedHill Biopharma Ltd (RDHL)

[noretreat]

I will be there...RedHill Biopharma to Present at the Biotech Showcase 2017


TEL-AVIV, Israel, Dec. 28, 2016 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (TASE:RDHL) (“RedHill” or the “Company”), a biopharmaceutical company primarily focused on development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for gastrointestinal and inflammatory diseases and cancer, today announced that Mr. Adi Frish, RedHill’s Senior VP Business Development and Licensing, will present a corporate overview at the Biotech Showcase 2017 conference, on Tuesday, January 10, 2017, at 9:30 am PST, at the Hilton San Francisco Union Square, San Francisco, CA.


A live audio of the presentation will be available on the Company's website at: http://ir.redhillbio.com/events.cfm. A copy of the presentation is available on the Company's website and a replay of the webcast will be available on the Company's website for a period of 30 days.